share_log

國藥控股:有關採購及銷售交易的持續關連交易:建議追認2021年度實際交易金額及 建議修訂2022年度及2023年度年度上限及暫停辦理股份過戶登記

SINOPHARM: CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PROCUREMENT AND SALES TRANSACTIONS: PROPOSED RATIFICATION OF THE 2021 ACTUAL TRANSACTION AMOUNTS PROPOSED REVISION OF THE ANNUAL CAPS FOR 2022 AND 2023 AND CLOSURE OF REGISTER OF MEMBERS

Hong Kong Stock Exchange ·  Mar 20, 2022 19:15
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more